Because the nuclear factor kappa‐B (NF‐κB) pathway plays an important role in the occurrence of AML, we studied the impact of SEP treatment on the regulation of immune and inflammatory responses.14 The gene discussed is NFKB1; the disease is acute myeloid leukemia.